Related Experiment Videos
Hemoccult II test: routine screening procedure for colorectal neoplasm?
The Medical Journal of Australia
|June 13, 1981
Summary
The Hemoccult II Test screened nearly 4,500 individuals, identifying 13 colorectal cancer cases. This early detection method showed a 0.29% cancer incidence, supporting its use in colorectal cancer screening programs.
Area of Science:
- Gastroenterology
- Oncology
- Public Health
Background:
- Colorectal cancer screening is crucial for early detection and improved patient outcomes.
- The Hemoccult II Test, a fecal occult blood test, was implemented for widespread screening.
- Sydney Hospital initiated a screening program to evaluate the test's effectiveness.
Purpose of the Study:
- To assess the yield of colorectal neoplasms, including carcinomas, using the Hemoccult II Test in a screening setting.
- To determine the incidence of colorectal cancer detected through this screening procedure.
- To compare findings with similar international studies.
Main Methods:
- The Hemoccult II Test was administered to a cohort of 4498 individuals.
- Positive results prompted referral for further investigation.
- Patients attended outpatient clinics for diagnostic evaluation and follow-up.
Main Results:
- Out of 4498 screened individuals, 150 had positive Hemoccult II Test results.
- 114 patients underwent further investigation at Sydney Hospital's outpatient clinic.
- Forty-four patients were diagnosed with 59 colorectal neoplasms, including 13 carcinomas.
Conclusions:
- The Hemoccult II Test identified colorectal neoplasms, including 13 carcinomas, in a screened population.
- The study demonstrated a colorectal cancer incidence of 0.29% in the screened cohort.
- These findings corroborate the efficacy of fecal occult blood testing in colorectal cancer screening.